Healthcare provider profile · identity verified

Needhi Pattani, D.O.

Family Practice · PHILADELPHIA, PA · NPI 1528595287

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	192
Amlodipine Besylate	Amlodipine Besylate	355	110
Gabapentin	Gabapentin	330	73
Metformin Hcl	Metformin Hcl	279	75
Albuterol Sulfate Hfa	Albuterol Sulfate	260	63
Pantoprazole Sodium	Pantoprazole Sodium	255	63
Losartan Potassium	Losartan Potassium	227	59
Nifedipine Er	Nifedipine	213	54
Hydrochlorothiazide	Hydrochlorothiazide	192	56
Omeprazole	Omeprazole	184	57
Lisinopril	Lisinopril	160	48
Rosuvastatin Calcium	Rosuvastatin Calcium	158	44
Carvedilol	Carvedilol	136	39
Levothyroxine Sodium	Levothyroxine Sodium	127	26
Ozempic	Semaglutide	124	18
Metoprolol Succinate	Metoprolol Succinate	119	38
Fluticasone Propionate	Fluticasone Propionate	96	25
Furosemide	Furosemide	95	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	91	16
Eliquis	Apixaban	91	24
Famotidine	Famotidine	88	20
Januvia	Sitagliptin Phosphate	87	19
Trulicity	Dulaglutide	87	17
Metoprolol Tartrate	Metoprolol Tartrate	82	22
Lidocaine	Lidocaine	78	17
Jardiance	Empagliflozin	72	21
Ezetimibe	Ezetimibe	69	20
Montelukast Sodium	Montelukast Sodium	68	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	59	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	22
Trazodone Hcl	Trazodone Hcl	54	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	52	13
Farxiga	Dapagliflozin Propanediol	51	14
Diclofenac Sodium	Diclofenac Sodium	48	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	11
Warfarin Sodium	Warfarin Sodium	47	suppressed
Alendronate Sodium	Alendronate Sodium	46	13
Bumetanide	Bumetanide	46	suppressed
Allopurinol	Allopurinol	45	11
Chlorthalidone	Chlorthalidone	45	14
Clopidogrel	Clopidogrel Bisulfate	44	14
Hydralazine Hcl	Hydralazine Hcl	44	11
Sertraline Hcl	Sertraline Hcl	43	12
Spironolactone	Spironolactone	42	12
Simvastatin	Simvastatin	41	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	40	13
Pravastatin Sodium	Pravastatin Sodium	39	11
Levetiracetam	Levetiracetam	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Entresto	Sacubitril/Valsartan	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Glipizide	Glipizide	35	12
Glipizide Er	Glipizide	35	11
Symbicort	Budesonide/Formoterol Fumarate	35	16
Valacyclovir	Valacyclovir Hcl	35	suppressed
Celecoxib	Celecoxib	34	suppressed
Ibuprofen	Ibuprofen	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Potassium Chloride	Potassium Chloride	34	13
Tamsulosin Hcl	Tamsulosin Hcl	34	12
Valsartan	Valsartan	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	33	suppressed
Novolog Flexpen	Insulin Aspart	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Xarelto	Rivaroxaban	30	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Baclofen	Baclofen	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Latanoprost	Latanoprost	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Single Use Swab	Alcohol Antiseptic Pads	19	suppressed
Cilostazol	Cilostazol	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Clonidine	Clonidine	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Naproxen	Naproxen	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error